Nicole Lambert
Directeur/Membre du Conseil chez ARCUS BIOSCIENCES, INC.
Fortune : 5 M $ au 31/05/2024
Profil
Nicole Lambert is an Independent Director at Arcus Biosciences, Inc. and President at Myriad Genetic Laboratories, Inc. She was previously the Chief Operating Officer at Myriad Genetics, Inc. She received her undergraduate degree from Boston College and her graduate degree from Icahn School of Medicine at Mount Sinai.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
MYRIAD GENETICS, INC.
0,25% | 11/04/2024 | 223 993 ( 0,25% ) | 5 M $ | 31/05/2024 |
ARCUS BIOSCIENCES, INC.
0,03% | 06/06/2024 | 24 000 ( 0,03% ) | 361 680 $ | 31/05/2024 |
Postes actifs de Nicole Lambert
Sociétés | Poste | Début |
---|---|---|
ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 03/08/2021 |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | President | - |
Anciens postes connus de Nicole Lambert
Sociétés | Poste | Fin |
---|---|---|
MYRIAD GENETICS, INC. | Directeur des opérations | 31/10/2023 |
Formation de Nicole Lambert
Icahn School of Medicine at Mount Sinai | Graduate Degree |
Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Commercial Services |